_1777294237270_124456903.png&w=64&q=75){kind=small}
Jamjoom Pharma Q3 profits reach 110.21M Riyals
Jamjoom Pharma announced a rise in its profits for the third quarter of 2026, with net profit reaching 110.21 million Riyals, an increase of 3.32% compared to the same period last year. This growth was driven by higher revenues and improved gross margins due to production efficiency, a better product mix, and expanded geographic distribution. Although profits declined by 19.92% compared to the previous quarter, the company achieved a 3.61% increase in revenues and a 6.88% rise in gross profit. For the first nine months of the year, the company's profits grew by 5.13%, reaching 416.05 million Riyals, with revenues up 7.13% to 1.281 billion Riyals, and shareholders’ equity increased by 10.58% to 1.827 billion Riyals.
Notice: This Is an AI-Generated Summary
Comments (0)